Cardiovascular Systems Inc
F:R7Y1
Net Margin
Cardiovascular Systems Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
C
|
Cardiovascular Systems Inc
F:R7Y1
|
755.4m EUR |
-16%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
218.9B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
159.4B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
153.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
118B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.3B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.7B USD |
23%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
40.1B USD |
26%
|
Cardiovascular Systems Inc
Glance View
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 780 full-time employees. The company went IPO on 2006-06-28. The firm has developed patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Cardiovascular Systems Inc's most recent financial statements, the company has Net Margin of -15.8%.
You don't have any saved screeners yet